Skip to content

A comparative study of the anesthetic effect of Alfentanil versus Sufentanil in laryngeal microsurgery

A comparative study of the anesthetic effect of Alfentanil versus Sufentanil in laryngeal microsurgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104073
Enrollment
Unknown
Registered
2025-06-10
Start date
2025-05-29
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Throat diseases

Interventions

Test group :Induction of general anesthesia with Alfentanyl 25 µ g/kg, maintaining pump infusion of Alfentanyl 0.5-2 µ g · kg-1 · min-1 (concentration of 100 µ g/ml)
Control group:Induction of general anesthesia with Sufentanyl 0.3 µ g/kg.

Sponsors

Ziyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Gender is not limited. Age: 18 to 64 years old. 2. American Society of Anesthesiologists (ASA) physical status classification I to II. 3. Body Mass Index (BMI): 18 kg/m² to 30 kg/m².

Exclusion criteria

Exclusion criteria: 1. Refusal to participate in the study 2. Pregnancy and lactation 3. Allergy to opioids or propofol 4. ASA grade III or above 5. NYHA cardiac function classification grade III to IV 6. Uncontrolled severe hypertension or hypotension (systolic blood pressure = 160 mmHg, diastolic blood pressure = 100 mmHg, systolic blood pressure = 90 mmHg, diastolic blood pressure = 60 mmHg, meeting any one of these criteria is sufficient) 7. Coronary heart disease or severe arrhythmia 8. Severe liver or kidney disease 9. Severe neurological or mental system diseases 10. Long-term regular use of analgesics, psychotropic drugs (including opioids, sedatives, antidepressants, antiepileptic drugs), and a2-adrenergic receptor agonists within 3 months before the start of the screening period. 11. Communication barriers.

Design outcomes

Primary

MeasureTime frame
Maximum rate of change in systolic and diastolic pressure after endotracheal intubation and after placement of the supporting laryngoscope;The stability of RPP after endotracheal intubation and support laryngoscope placement (RPP is the product of heart rate and systolic blood pressure, i.e. SBP × HR);

Secondary

MeasureTime frame
Wake-up time;Pull out time;Visual Analog Scale for Pharyngeal Pain;Coughing reaction;Intubation reaction;

Countries

China

Contacts

Public ContactJiaman Li

Ziyang Central Hospital

625365621@qq.com+86 153 7867 3311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026